These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 28315877)

  • 1. The Value of lncRNA HULC as a Prognostic Factor for Survival of Cancer Outcome: A Meta-Analysis.
    Chen X; Lun L; Hou H; Tian R; Zhang H; Zhang Y
    Cell Physiol Biochem; 2017; 41(4):1424-1434. PubMed ID: 28315877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA HULC as a potential prognostic biomarker in human cancers: a meta-analysis.
    Fan YH; Wu MJ; Jiang Y; Ye M; Lu SG; Wu L; Zhu XG
    Oncotarget; 2017 Mar; 8(13):21410-21417. PubMed ID: 28199963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Significance of Long Non-coding RNA HULC in Predicting Prognosis and Metastasis of Cancers: a Meta-Analysis.
    Ding Y; Sun C; Li J; Hu L; Li M; Liu J; Pu L; Xiong S
    Pathol Oncol Res; 2019 Jan; 25(1):311-318. PubMed ID: 29110261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Value of lncRNA NEAT1 as a Prognostic Factor for Survival of Cancer Outcome: A Meta-Analysis.
    Zhang Y; Lun L; Li H; Wang Q; Lin J; Tian R; Pan H; Zhang H; Chen X
    Sci Rep; 2017 Oct; 7(1):13080. PubMed ID: 29026116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic role of lncRNA TUG1 for cancer outcome: Evidence from 840 cancer patients.
    Liu J; Lin J; Li Y; Zhang Y; Chen X
    Oncotarget; 2017 Jul; 8(30):50051-50060. PubMed ID: 28548946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TUG1, SPRY4-IT1, and HULC as valuable prognostic biomarkers of survival in cancer: A PRISMA-compliant meta-analysis.
    Zhong Y; Chen Z; Guo S; Liao X; Xie H; Zheng Y; Cai B; Huang P; Liu Y; Zhou Q; Liu Y; Huang W
    Medicine (Baltimore); 2017 Nov; 96(46):e8583. PubMed ID: 29145271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA PANDAR is a Novel Prognostic Biomarker in Patients with Cancer: a Meta-Analysis.
    Tian L; Chen X; Lun L; Tian Q; Wang Q; Li H; Song J; Jing X; Zhang Y; Tian R
    Clin Lab; 2019 Jan; 65(1):. PubMed ID: 30775883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Value of lncRNA GHET1 as a Prognostic Factor for Survival of Chinese Cancer Outcome: A Meta-Analysis.
    Song J; Chen X; Tian Q; Lun L; Wang Q; Wang H; Li X; Liu Z; Tian L; Jing X; Zhang Y; Tian R
    Dis Markers; 2019; 2019():5824190. PubMed ID: 31885739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of lncRNA SNGH3 Predicts Unfavorable Prognosis and Clinical Outcomes in Human Cancers: Evidence from a Meta-Analysis.
    Jiang Y; Le L
    Biomed Res Int; 2020; 2020():7974034. PubMed ID: 32802874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA HULC as a potential predictor of prognosis and clinicopathological features in patients with digestive system tumors: a meta-analysis.
    Li D; Wang R; Wu N; Yu Y
    Aging (Albany NY); 2022 Feb; 14(4):1797-1811. PubMed ID: 35183058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of lncRNA SOX2OT for Chinese cancer patients: A meta-analysis.
    Jing X; Lin J; Wang H; Tian L; Tian R; Zhang Y; Chen X; Zhang J
    PLoS One; 2017; 12(5):e0176889. PubMed ID: 28489861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological and prognostic value of SNHG6 in cancers: a systematic review and a meta-analysis.
    Zhang S; Qiu D; Xie X; Shen Y
    BMC Cancer; 2020 Apr; 20(1):343. PubMed ID: 32321469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of lncRNA AGAP2-AS1 in cancer patients: A meta-analysis.
    Zhong P; Hua H; Chen S; Zhu Z; Xie F
    Medicine (Baltimore); 2021 Dec; 100(51):e28425. PubMed ID: 34941192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA X-inactive specific transcript as a prognostic factor in cancer patients: A meta-analysis based on retrospective studies.
    Chen J; Yang X; Gong D; Cui Y; Hu J; Li H; Liu P; Li C; Cheng X; Liu L; Chen H; Zu X
    Medicine (Baltimore); 2019 Jan; 98(3):e14095. PubMed ID: 30653128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic and clinicopathologic significance of long non-coding RNA opa-interacting protein 5-antisense RNA 1 in multiple human cancers.
    Ren X; He J; Qi L; Li S; Zhang C; Duan Z; Wang W; Tu C; Li Z
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):353-361. PubMed ID: 31899963
    [No Abstract]   [Full Text] [Related]  

  • 16. AlncRNA HULC as an effective biomarker for surveillance of the outcome of cancer: A meta-analysis.
    Chen X; Lin J; Liu Y; Peng J; Cao Y; Su Z; Wang T; Cheng J; Hu D
    PLoS One; 2017; 12(2):e0171210. PubMed ID: 28146578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic value of lncRNA SNHG1 in cancer patients: a meta-analysis.
    Dong B; Chen X; Zhang Y; Zhu C; Dong Q
    BMC Cancer; 2019 Aug; 19(1):780. PubMed ID: 31391030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. lncRNA PVT1 in cancer: A review and meta-analysis.
    Lu D; Luo P; Wang Q; Ye Y; Wang B
    Clin Chim Acta; 2017 Nov; 474():1-7. PubMed ID: 28866116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological significance and prognosis of long noncoding RNA SNHG16 expression in human cancers: a meta-analysis.
    Jiao R; Jiang W; Wei X; Zhang M; Zhao S; Huang G
    BMC Cancer; 2020 Jul; 20(1):662. PubMed ID: 32677912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of CD44V6 expression in osteosarcoma: a meta-analysis.
    Zhang Y; Ding C; Wang J; Sun G; Cao Y; Xu L; Zhou L; Chen X
    J Orthop Surg Res; 2015 Dec; 10():187. PubMed ID: 26697855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.